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Abstract
Finding new drug targets for pathogenic infections would be of great utility for humanity, as there is a large need to
develop new drugs to fight infections due to the developing resistance and side effects of current treatments. Current drug
targets for pathogen infections involve only a single protein. However, proteins rarely act in isolation, and the majority of
biological processes occur via interactions with other proteins, so protein-protein interactions (PPIs) offer a realm of
unexplored potential drug targets and are thought to be the next-generation of drug targets. Parasitic worms were chosen
for this study because they have deleterious effects on human health, livestock, and plants, costing society billions of dollars
annually and many sequenced genomes are available. In this study, we present a computational approach that utilizes
whole genomes of 6 parasitic and 1 free-living worm species and 2 hosts. The species were placed in orthologous groups,
then binned in species-specific ortholgous groups. Proteins that are essential and conserved among species that span a
phyla are of greatest value, as they provide foundations for developing broad-control strategies. Two PPI databases were
used to find PPIs within the species specific bins. PPIs with unique helminth proteins and helminth proteins with unique
features relative to the host, such as indels, were prioritized as drug targets. The PPIs were scored based on RNAi phenotype
and homology to the PDB (Protein DataBank). EST data for the various life stages, GO annotation, and druggability were also
taken into consideration. Several PPIs emerged from this study as potential drug targets. A few interactions were supported
by co-localization of expression in M. incognita (plant parasite) and B. malayi (H. sapiens parasite), which have extremely
different modes of parasitism. As more genomes of pathogens are sequenced and PPI databases expanded, this
methodology will become increasingly applicable.
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Introduction
Roundworm and flatworm infections, known as helminth
infections, are an enormous problem worldwide, especially in
developing countries. About one-third of earth’s population are
infected with parasitic helminths[1]. These parasite infections can
range from diseases such as elephantiasis and river blindness[2] to
detrimental effects on child development and health[3]. Further,
helminths have devastating effects on crops, costing $78 billion per
year globally[4], and infect domesticated animals, which costs
billions of dollars[5]. Anthelminthic drug resistance is an
increasing problem[6], so pesticide, drug and vaccine development
for parasite infections would have a great impact on improving
world health and productivity.
With recent whole genome sequencing efforts, several parasitic
genomes have been sequenced and much information important
for drug discovery can be mined[7]. Several published reports
used genomic data to prioritize parasitic drug targets using three
main approaches. One method examined all genes in the genome
encoding specific types of receptors known to be important for
parasitic survival[8,9]. Metabolic chokepoints or essential proteins
in metabolic pathways have been targeted for drug prioritiza-
tion[10,11,12,13]. A third approach determined orthologous
groups of proteins in various parasites, model organisms, and
humans. The orthologous protein groups were used to extract
experimental information, such as RNAi and expression data, for
prioritization or to place higher priority on proteins that were not
in the host genomes or have high homology to the PDB (Protein
DataBank) [14,15,16,17,18].
These previous drug prioritization approaches target single
specific proteins. In fact, the traditional approach for drug
discovery involves targeting a single enzyme active site with a
small molecule[19]. However, proteins rarely act in isolation and
often interact with other proteins to accomplish their biological
function, forming protein-protein interaction (PPI) networks[20].
Given large-scale genomics and proteomics initiatives, entire
interactomes have been identified, leading to important insights
into biological pathways and host-pathogen interaction[21]. PPIs
are of central importance and are involved in nearly all cellular
processes[22], making these interactions important targets for drug
discovery[23]. While PPIs are challenging targets due to the large
surface area and shallow interaction at the protein-protein
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interface, their recent success as drug targets has been report-
ed[19]. Targeting PPIs targets can increase the number of drug
targets dramatically[24] and offer the next large innovation in
drugs that will be released in the next decade[21].
The increase in the number of full genome sequences and
various PPI databases presents an opportunity to apply a
computational approach to find novel PPI drug targets. By using
all complete genomes of roundworms (Nematoda) and flatworms
(Platyhelminthes) available presently, we have identified PPIs
unique to certain groups of parasites or that have molecular
features unique to Nematoda and/or Platyhelminthes relative to
their hosts. Several PPIs were tested via in situ hybridization to
confirm the co-localization of protein expression in the human
parasite Brugia malayi and the plant parasite Meloidogyne incognita.
The methodology used for drug prioritization in this study was
guided by the wealth of functional information available for the
model nematode Caenorhabditis elegans. While as a prototype we
used species from two phyla, the approach could be applied to any
phyla in which several pathogenic species have a sequenced
genome.
Results
Orthologous groups
Markov Clustering of the 156,825 proteins (originating from 9
species (Table 1)) resulted in 21,293 orthologous groups (available
on nematode.net[25]) which were placed in species specific bins
and enumerated (Figure 1 & 2A,B). The number of orthologous
groups in the bins decreases dramatically, in some cases more than
10 fold, when helminth-specific proteins are allowed in a bin (i.e.
host proteins are excluded). The number of orthologous groups
decreases less than 21% when a C. elegans protein is required in the
orthologous group. However, the number of orthologous groups
with platyhelminths significantly decreases when C. elegans are
included and humans excluded. The large number of orthologous
groups that contain a host ortholog in addition to the set of
nematode and platyhelminth proteins shows that when proteins
are conserved across a phyla, they are likely to be conserved in
other branches of the phylogenic tree. Relatively few orthologous
groups specific to both nematodes and platyhelminthes lack an
ortholog in the human host. These proteins are of interest, as they
are taxonomically restricted and conserved among helminths, and
therefore, they are possible targets for broad and general control of
helminths. Interestingly, there are more orthologous groups when
Arabidopsis thaliana is excluded from the orthologous group,
compared to being included, with the plant parasites compared,
indicating more unique nematode–specific proteins when com-
pared to plant. This is not surprising because A. thaliana (kingdom
Viridiplantae) is much more evolutionarily divergent than humans
and worms (kingdom Metazoa). Hence, based on our results,
targeting the plant parasite-specific proteins has potential to be a
fruitful area of research.
PPIs
PPI databases are heavily populated with C. elegans PPIs and
have nearly no PPIs for other nematodes and platyhelminths.
Therefore, only bins containing C. elegans orthologs were analyzed
for prioritizing PPIs, (Figure 2C,D). Using multiple databases
expanded the number of potential targets due to the unique PPIs
per database. Bins where human orthologs were excluded had a
smaller number of PPIs than bins where proteins with human
orthologs were considered. The bins where human orthologs were
included had many more PPIs, yielding more potential drug
targets. In the PPI databases, a small number of PPIs were
mapped versus the total number of proteins in the proteome (C.
elegans has 24,052 proteins of which 4,159 are in the IntAct PPIs
and 3,257 in the MINT PPIs), but the numbers are expected to
increase as more experimental PPIs are discovered. Based on our
scoring function (see Methods) we provide a ranked list of potential
PPI drug targets (Table 2). The results of Bin 12 for PPI-Indel1
and PPI-Indel2 (see Methods) are also presented in a ranked list in
the Tables S1, S2, and S3. Table S4 provides the score broken into
various terms to aid in evaluating each PPI.
Potential Drug Targets
PPI-Indel1. PPIs in PPI-Indel1 provide a unique position to
specifically target the interaction with helminth proteins without
disrupting the interaction between orthologous human proteins.
The interaction between O01427 and Q19126 was found in C.
elegans via yeast two hybrid[26] and was chosen for FISH testing in
B. malayi (Table 2) because of the C. elegans expression data
available. Found in Bins 3, 7, 17, 21, both proteins in this
Table 1. Information regarding parasite and host species studied.
Species
Number of
proteins
Number of
proteins without
isoforms
Trophic
ecologya Proteome Resource
B. malayi 11,610 11,407 HPN WS175; www.wormbase.org
C. elegans 24,052 20,173 FLN WS204; www.wormbase.org
M. hapla 14,421 14,421* PPN http://supfam.mrc-lmb.cam.ac.uk/SUPERFAMILY/cgi-bin/gen_list.cgi?genome=wm
M. incognita 20,359 19,212 PPN http://www.inra.fr/meloidogyne_incognita/genomic_resources/downloads
S. japonicum 13,469 13,469* HPF v4.0 (http://www.chgc.sh.cn/japonicum/Resources.html)
S. mansoni 11,789 11,789* HPF v4.0 (http://www.genedb.org/)
T. spiralis 16,124 16,124* HPN GenBank Acc: ABIR00000000.2b
H. sapiens 37,868 24,013 Host (ftp://ftp.ncbi.nih.gov/refseq/H_sapiens/mRNA_Prot/human.rna.gbff.gz)
A. thaliana 28,952 26,217 Host ftp://ftp.ncbi.nih.gov/genomes/Arabidopsis_thaliana/GNOMON and ftp://ftp.arabidopsis.org/
home/tair/Sequences/blast_datasets
*Alternative splicing not known, so entire proteome was used.
aHPN – human parasitic nematode, FLN – free-living nematode, PPN – plant parasitic nematode, HPF – human parasitic flatworm.
bThe protein set used in this study is slightly larger than what was submitted to GenBank.
doi:10.1371/journal.pone.0018381.t001
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interaction have very severe RNAi phenotypes in C. elegans and
high homology to the PDB. O01427 has more interactions (5) than
Q19126 (1). Both transcripts were found to be differentially
expressed in the large roundworm, Ascaris suum, male intestines
and head. In C. elegans, O01427 is localized to meiotic
chromosomes in both the oocytes and gonads; Q19126 was
expressed widely and continuously in the entire body in C. elegans.
O01427 functions as a serine/threonine kinase (IPR008271,
IPR017442, IPR002290), which plays an important role
activating several downstream pathways. Q19126 is a protein
associated with ATPase synthase (IPR008688) and is part of
subunit b of the peripheral stalk on F-ATPase. O01427 is
considered a druggable domain by Hopkins criteria and has two
deletions relative to vertebrate homologs which were modeled for
further characterization.
TASSER-Lite was used to create the homology model because
an ab initio approach was needed to model unresolved structure of
the variable-length N-terminal end where the indels were located.
The longest H. sapiens sequence (host) in the orthologous group
and B. malayi (parasite and subject of FISH experiment) were
modeled. The H. sapiens predicted structure has two small indels
that are not found in nematodes (Figure 3A,B and Figure S1). The
secondary structure prediction of the N-terminal end is mainly a
loop with no defined beta sheet or alpha helical structure and was
unresolved in the X-ray crystal structure, which may indicate
disorder; the secondary structure of the remainder of the protein is
conserved. However, two independent predictors suggested the H.
sapiens protein has mainly alpha-helical character. Like many PPIs,
this protein might undergo a disorder-to-order transition upon
binding its protein partner[27], making the PPI target easy to
disrupt. The difference in the disordered region and indels
between H. sapiens and nematodes provides a specific mechanism
for targeting O01427/Q19126.
The C. elegans interaction between O01427 and Q19126 was
tested in B. malayi using FISH. Both FISH antisense probes showed
a distinct and tightly developmentally regulated mRNA hybrid-
ization pattern (Fig. 3C, Figure S2 and Video S1). Expression of
the Q19126[XP_00189449.1] gene was mainly detected in egg
cells and developing embryos. Weak staining was observed in the
hypodermal region and the uterus epithelium (Figure S2).
Although multiple sections of female and male B. malayi worms
were examined for the expression of the
Q19126[XP_00189449.1] gene, the most striking signal was
obtained in the uterine egg cells and developing embryos.
Therefore, the further analysis was focused on these structures.
Expression of the O01427[XP_001892118.1] gene was slightly
weaker for the Q19126[XP_00189449.1] gene and almost
exclusively confined to egg cells and embryos. However, in the
morula stage, embryo expression of both genes was clearly co-
localized, especially in areas with less densely condensated
chromatin (Figure 3C, Figure S2 F,G). The intracellular
distribution of both messages was distinct within the cytoplasm.
Localization of gene expression in the same tissue within B. malayi,
in addition to the PPI between O01427 and Q19126 found in C.
elegans via yeast 2-hybrid, we surmise that this PPI likely exists in
other nematode species and may be a good drug target.
PPI-Indel2. The interaction between P46822 (insertion) and
Q17581 (deletion) had the most promising expression data from
PPI-Indel2 over many life stages in B. malayi (Table 2). As a kinesin
light chain, P46822 makes many PPIs in the cell to carry out its
function and this is reflected in the number of PPIs emanating
from this hub with 20 and 21 PPIs in MINT and IntAct,
respectively. Typically moving from the minus end to the plus end
of a microtubule, the kinesin light chain binds to the cargo being
transported. Q17581 makes 2 PPIs in MINT and IntAct. The
NCBI KOG (clusters of euKaryotic Orthologous Groups) classifies
this protein as a CELTIX-1 protein containing a bromodomain
that binds to IRF-2, a transcription factor. The bromodomain
specifically recognizes acetylated lysines. In addition, co-
localization between P46822 and Q17581 was detected by
FISH, and a complementary in situ method, in pretzel stage
embryos of B. malayi (Figure S2). While weak labeling of RNA
granules was observed in tissues of adult worms, specific expression
was found in developing embryos. This target is discussed further
in the Text S1. The localization of Q19207/Q95005, another pair
within PPI-Indel1, was also found in the same tissue (data not
shown).
PPI-Nem. The majority of hits from PPI-Nem (nematode-
specific PPIs) had a uniprot classification of zinc finger, integrase,
or serine-kinase (Table 2). Q20329 is an actin protein, and
Figure 1. Flow chart of methodology to find PPI drug targets. The longest protein isoform in nine different proteomes were placed in
orthologous groups. The orthologous groups were placed in species-specific bins (The numbers of orthologous groups within species-specific bins
are shown in the Venn diagrams below). Protein interaction data from MINT and IntAct were used to find groups that contained PPIs. The PPIs were
scored and analyzed based on GO annotation, ESTs, and microarray data, then characterized using molecular modeling and experimental techniques.
doi:10.1371/journal.pone.0018381.g001
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Q03601 has a zinc finger protein NHL-1 at the C-terminal region
that forms a beta-propeller twist and contains a coiled-coil region
near the N-terminal end of some of the nematode proteins. Co-
localization of Q20329/Q03601 was detected in the anterior
intestines and pharynx of M. incognita (Figure S3, Table S5).
Despite both proteins being grouped in a nematode specific bin,
the primary sequence similarity results revealed some homology to
human proteins. Both proteins were modeled to determine if these
proteins differed from the H. sapiens proteins enough to be viable
drug targets (Figure S4). Differences between the electrostatics on
the surface of the nematode proteins themselves and H. sapiens
reflect opportunities for specific species targeting (Figures 4, S4,
Figure 2. Results of orthologous groups. A. Taxonomically restricted orthologous groups, based on OrthoMCL output, were parsed for PPIs. The
following abbreviations were used: HPN (human parasitic nematode): B. malayi and T. spiralis, FLN (free-living nematode): C. elegans, PPN (plant
parasitic nematode): M. incognita and M. hapla, HPF (human parasitic flatworms): S. mansoni and S. japonicum, Hs: H. sapiens, At: A. thaliana, B.
Distribution of orthologous groups within taxonomically restricted orthologous bins based on whether the host is included or excluded, C. Number
of MINT and IntAct PPIs in species-specific binds from the PPI-Nem group, D. Number of MINT and IntAct PPIs in species-specific bins from the PPI-
Indel group.
doi:10.1371/journal.pone.0018381.g002
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Table 2. The top 8 PPI targets in each of the three major groups: specific to nematodes (PPI-Nem), where both proteins contain
indels with respect to human host (PPI-Indel2), with one indel with respect to human host (PPI-Indel1).
PPI Score RNAi Phenoa
PDB
Homo. Frac. of Len PPI Groupb Function
Stagec
Localizationd
Q03601/
Q20329
253.7 21/
315
31.3/
30
0.81/
0.65
Nem
I
ZnFinger, NHL repeat/
actin-like
L1,Em,A / L1,L4,Eg,Em,A
PMR / ---
O45666*/
O45666*
237.8 32156/
32156
35/
35
0.53/
0.53
Nem
IM
NHR-Znfinger/
NHR-Znfinger
L1,L2,L4,Em,A / L1,L2,L4,Em,A
--- / ---
O45666*/
Q09528*
156.9 32156/
No
35/
25.9
0.53/
0.50
Nem
IM
NHR-Znfinger/
NHR-Znfinger
L1,L2,L4,Em,A / L,A
--- / ---
Q21234*/
Q21234*
150.0 215/
215
No No Nem
IM
Integrase L1,L2,L3,L4,Em,A/L1,L2,L3,L4,Em,A
--- / ---
Q8MYQ1/
Q22631
147.4 7/
No
39.6/
30.1
0.96/
0.54
Nem
IM
Ser-kinase/
thrombospondin
L1 / L1,L2,L4,Em
--- / ---
O01489/
O01489
135.0 2/
2
No No Nem
IM
ZnF protein L1,L2,L3,L4,Em,A / L1,L2,L3,L4,Em,A
PIMRNH / PIMRNH
Q03601/
O16266
75.0 21/
No
No No Nem
I
ZnFinger, NHL repeat/ L1,Em,A / Em
PMR / ---
Q9NDH1/
Q93413
67.5 No/
254
No No Nem
M
RNA-dep-RNA-pol/
DNA-RNA helicase
L1,L2,L3,L4,Em,A / L1,L2,L3,L4,Em,A
--- / S
Q93716+/
Q93716+
449.6 321576/
321576
100/
100
0.99/
0.99
Indel2
IM
NUDIX hydrolase domain L1,Em,A / L1,Em,A
PMH / PMH
P91988+/
P91988+
449.5 315/
315
100/
100
0.99/
0.99
Indel2
I
Flavoprotein L1,Em,A / L1,Em,A
--- / ---
Q20471+/
Q20471+
447.3 321546/
321546
100/
100
0.97/
0.97
Indel2
IM
Protein kinase L1,L4,Em,A / L1,L4,Em,A
--- / ---
P91851+/
P91851+
434.6 2/
2
100/
100
0.99/
0.99
Indel2
I
nicotinate-nucleotide
adenylyltransferase
Em,A / Em,A
--- / ---
O18209+*/
Q17796+
407.3 321/
321546
28/
41.5
0.51/
0.95
Indel2
IM
Protein Kinase/
Zinc finger
L1,L4,Em,A / L1,L4,Em,A
E / EHIPR
P46822+/
P46822+
396.3 2/
2
78.6/
78.6
0.83/
0.83
Indel2
IM
Tetratricopeptide L1,L4,Eg,Em,A / L1,L4,Eg,Em,A
--- / ---
P46822+/
Q17581+
392.7 2/
32154
78.6/
50.8
0.83/
0.88
Indel2
IM
Tetratricopeptide/
Bromodomain
L1,L4,Eg,Em,A/L1,Em,A
--- / ---
O62305+*/
O62305+*
391.4 No/
No
100/
100
0.91/
0.91
Indel2
I
Protein kinase L1,L4,Em,A / L1,L4,Em,A
--- / ---
P34475+*/
Q19207*
475.9 3217/
321546
99.5/
99.7
0.99/
0.53
Indel1
IM
Tubulin/ Hydroxymethylglutaryl-
CoA reductase
L1,L4,Em,A / L1,L2,Eg,Em,A
RE / ---
O01427+*/
Q19126
434.5 32174/
3215
100/
86.4
0.99/
0.83
Indel1
IM
Protein kinase/
ATPase
L1,L4,Em,A / L1,L4,Eg,Em,A
RE / whole body
P39745/
Q9BIB3+*
426.9 32157/
3215
100/
100
0.99/
0.54
Indel1
IM
Protein kinase/
Lipase
L1,L2,L4,Em,A / L1,A
--- / ---
Q95005/
Q19207+*
426.0 32156/
321546
100/
99.7
0.99/
0.53
Indel1
IM
Proteasome/
Hydroxymethylglutaryl-CoA
reductase
L1,L4,Em,A / L1,L2,Eg,Em,A
PM / ---
Q19207+*/
Q22799
425.7 3215746/
321546
99.7/
100
0.53/
0.98
Indel1
IM
Hydroxymethylglutaryl-CoA
reductase/Dynein light chain
L1,L2,Eg,Em,A / A
--- / PNI
P39745*/
O62305+*
420.6 32157/
No
100/
100
0.99/
0.91
Indel1
IM
Protein kinase like /
Protein kinase
L1,L2,L4,Em,A / L1,L4,Em,A
--- / ---
P39745*/
O16299+
413.6 32157/3 100/
65
0.99/
0.98
Indel1
IM
Protein kinase – like /
MCM protein 7
L1,L4,Em,A / L1,L2,L4,Em,A
--- / ---
P34442+*/
Q27488
406.1 21/32 40.3/
100
0.88/
0.99
Indel1
IM
Protein-tyrosine phosphatase /
Proteasome
L1,L4,Em,A / L1,L4,EgEm,A
EP / ---
The full list is in Table S1.
*indicates druggable, PPIs in bold italic were tested with FISH, and + indicates protein with indel, a RNAi phenotype 1 = Larval/Adult Lethal/Arrest, 2 = Embryonic Lethal,
3 = Sterility, 4 =Morphology, 5 =Growth, 6 =Movement, 7 = Vulva, 8 =Other; b Indicates analysis group (Nem, Indel2, and Indel1) and also the database where the PPI
was found (M=MINT and I = IntAct), c Stages are listed as L1, L2, L3, L4, egg (Eg), embryo (Em), and Adult (A), d Localization in C. elegans listed as pharynx (P), intestine (I),
reproductive (R), muscle (M), hypodermis (H), nervous system (N), somatic (S), embryo (E).
doi:10.1371/journal.pone.0018381.t002
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Figure 3. Characterization of O01427/Q19126. A. Multiple sequence and secondary structure alignment of vertebrate reference sequences
with selected nematode sequences. Within the secondary structure alignments, the random coiled regions are shown in yellow, the beta sheets are
shown in blue and helices are shown in red. The two boxed regions show the deletions in the worms relative to the vertebrates. B. Predicted 3D
structure of O01427 (H. sapiens protein in the orthologous group (red), B. malayi protein (blue), and indels (yellow)). C. Granular staining (arrows) for
Q19126 [XP_00189449.1] mRNA in the cytoplasm of morula stage embryos in the midbody region of a female B. malayi. The biotin labeled probe was
detected using AlexaFluor 488-labeled streptavidin (green). D. Identical section as in C showing granular staining (arrows) for O01427
[XP_001892118.1] mRNA in the same embryos. The digoxygenin labeled probe was detected using a Rhodamin conjugated anti-digoxygenin
antibody (red). e. Identical section as in c but DAPI stain (blue) showing differential degrees of chromatin condensation in the embryos. f. Overlay of
c-e showing co-localization of mRNA expression of Q19126 and O01427 (arrows) especially in embryos with less densely condensed chromatin.
Hybridization of sense probe for Q19126 (g.) and O01427 (h.) on a serial section to c showing the absence of a specific labeling. i. Overlay of g and h
including a DAPI stain (blue) showing the morula stage embryos with different degrees of chromatin condensation but the absence of a specific
hybridization signal. Scale bar 10 mm.
doi:10.1371/journal.pone.0018381.g003
Figure 4. 3D homology models of the nematode proteins and the host orthologs for the PPI partners Q03601/Q20329. A. B. malayi
and H. sapiens homology models of Q03601; B. B. malayi and H. sapiens homology models of Q20329; and C. M. hapla and A. thaliana homology
models of Q20329. All models are colored by electrostatic potential in vacuum. Q03601 did not have any protein sequences in A. thaliana with
homology to M. hapla andM. incognita. Although regions of these proteins have homology to H. sapiens (A and B) and A. thaliana (C), the charges on
the surface of H. sapiens and A. thaliana proteins are different from the charges on the surface of the nematode proteins. Further, Markov clustering
did not group the H. sapiens or A. thaliana proteins in the same orthologous groups as the nematode proteins.
doi:10.1371/journal.pone.0018381.g004
Targeting PPIs for Parasitic Control
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S5). Additional information is in the Text S1 and Tables S6, S7,
S8, S9, S10, S11.
Discussion
We demonstrated the validity of a novel approach for genomic-
scale prioritization of drug targets applicable for any pathogens of
medical and socio-economic importance. The methodology
developed takes advantage of the fact that a vast majority of the
biological processes occur via interactions of multiple proteins, and
therefore the interactions can be considered as putative good
targets for developing control strategies. Targeting interactions
between proteins with drugs expands the number of drug targets
dramatically from which pioneering therapies for pathogens that
plague over one-third of the earth’s population could be realized.
Given the increase in genomic sequencing of nematodes and
platyhelminthes, we used comparative genomics to derive novel
PPI drug targets from which broad-control strategies could be
developed. The methods used in this study are directly pertinent to
other parasitic phyla where genomes of several species have been
sequenced and will grow in applicability as more genomes and
large-scale genomics and proteomics efforts are realized.
There are two major classes of PPIs found in this study:
nematode specific proteins (PPI-Nem) and proteins with human
orthologs containing nematode specific indels (PPI-Indel). PPI-
Nem can be easily targeted without concern because the proteins
are specific to nematodes. The PPI-Indel group is quite large and
many potential PPIs would be eliminated if these were not
considered. Insertions and deletions (indels) are one distinguishing
feature that can provide a unique mechanism for targeting
proteins in nematodes and platyhelminthes relative to their human
orthologs. Indels have been shown to remodel PPI interaction
networks[28], and despite the proteins having human orthologs,
the proteins may not interact in humans due to the nematode
specific indels. Further, there has been some success in targeting
the indel region of a protein for drug discovery[29]. Other studies
have found that indels were more likely to occur in essential
proteins and those that are highly connected[30]. We identified
PPI targets that are in both the PPI-Nem and PPI-Indel groups for
further testing as drug targets.
Because there is no direct evidence that disrupting the PPIs in
this study would have a negative impact on nematode or
platyhelminth survival, the assumption was made that if two
proteins interacted and had a severe RNAi phenotype in C. elegans,
the PPI between these two proteins may be important for survival,
as well. Further evaluation of the essentiality of the PPI will be
necessary when the targets are pursued further. For PPI-Nem,
many of the PPIs found did not have an RNAi phenotype
available, causing their scores to be lower. Interactions where only
one protein has a severe RNAi phenotype could be promising drug
targets, but more RNAi experimentation should be done to
determine the RNAi phenotype of the other protein in the
interaction pair. For PPI-Indel, nearly all (x of y) the PPIs that
ranked highly had a severe RNAi phenotype.
Co-localization of proteins can be considered a prerequisite for
direct PPIs. In the absence of specific antibodies to candidate
proteins, co-localization of mRNA expression using ISH is an
alternative indicator for PPIs. Tissue-specific localization of
protein expression in B. malayi has been used to confirm gender
regulated protein expression and as pointer to protein func-
tion[31]. While using the PPI database originating from C. elegans
to infer PPIs in the parasitic species, we used ISH and synthetic
oligonucleotides to study the localization of mRNAs of four pairs
of candidate PPIs in two species with very distinct mode of
parasitism, the human parasite B. malayi and/or the plant-parasite
M. incognita. This technique allowed tissue-specific localization of
the mRNAs of protein pairs in egg cells and developing embryos
or in the anterior intestines and pharynx. As part of the
development process, targets that yielded promising results via
ISH should be tested using alternative techniques such as yeast
two-hybrid assay or co-immunoprecipitation to confirm the
protein-protein interaction, and biophysical techniques should be
used to determine KD. Development of a two-hybrid assay for
these PPIs also provides a means for screening small molecule
drugs that could potentially block the protein-protein interaction.
Certain types of proteins are considered better drug targets than
others. Based on Hopkins’ work[32], druggable proteins are
targets to which drugs that follow Lipinski’s rule-of-five bind[33].
Almost half of the targets found by Hopkins et al, fall into six main
protein catagories: G-protein coupled receptors (GPCRs), serine/
threonine and tyrosine protein kinases, zinc metallopeptidases,
serine proteases, nuclear hormone receptors, and phosphodiester-
ases. For PPI-Nem, the druggability was evaluated, but for the
PPI-Indel group, the druggability was added to the scoring
function to allow differentiation among a much larger dataset. For
PPI-Nem, three of the PPIs had domains that were considered
druggable (Table 2 and Table S1 and S4). One would have
expected this number to rise for PPI-Indel, considering there were
more PPI targets and the scoring function was weighted toward
PPIs that were druggable. However, only two PPIs in the top set of
PPI-Indel2 had one or more druggable domains (Table 2, Table
S1 and S4). The number of druggable domains increased
significantly for the PPI-Indel1 group. Interestingly, there are
more homooligomeric interactions in PPI-Indel2 versus PPI-
Indel1 due to the weighting of the indels in the scoring function. If
a protein homooligomerizes and has an indel, it automatically gets
a 100 added to its score relative to others, causing the interaction
to be ranked higher. Homooligomeric interactions may have
evolved to be species specific by changing their interaction surface
via indels.
To potentially design drugs for PPIs, either a structure in the
PDB or homology to a structure in the PDB is helpful. The
database of sequences in the PDB contains information for the
entire sequence that was crystallized and tested; the database does
not take into account regions that are unresolved in the crystal
structure. Therefore, the length of the protein suggested from the
primary sequence similarity search may not reflect the model
resolved in the X-ray crystal structure. Other studies have used
BLASTP to compare the query sequences to the PDB sequence
database, not taking the unresolved part of the structure into
account when considering homology to the PDB[14,15]. In the
future, running a disorder prediction algorithm, such as DIS-
OPRED[34], on all the sequences would be useful. In general,
fewer PPIs for PPI-Nem had homology to the PDB, than those
that had RNAi phenotype.
To our knowledge there is only one study on genome-wide drug
prioritization in parasitic nematodes[15]. As a test of this
methodology, we compared our results to this very different study
in which individual proteins were prioritized as drug targets for B.
malayi[15]. Two of our PPIs from PPI-Nem (O01489/O01489 and
Q21234/Q21234) and two proteins from the PPI-Indel group
(Q20228/Q9GYK4 and Q20308/Q9U329) were also identified
in Kumar et al[15]. The Kumar et al. study did not take into
account indels that could be used to uniquely target nematode
proteins. Despite the presence of these proteins in the list of the B.
malayi study, the only way to target these proteins in helminths
without also interacting with humans is through differences in
sequence homology or indels. In addition to these proteins, there
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were other proteins in the orthologous groups that overlapped
with the set found in the B. malayi paper. However, one of the
proteins in the PPI lacked homology to the PDB and was not
scored. These proteins include: Q93731/Q20775, O76258/
O44158, Q20228/Q9GYK4, Q20775/Q93647, P92004/
O62215, Q09252/Q965W3, Q20308/Q9U329, O45904/
Q9XWD5, O44991/P91318.
Interestingly, the majority of the targets found in our study have
expression in the pharynx and intestines. These are excellent sites
for drug targeting in helminthes[35,36]. To determine if this was
enrichment for expression in tissue in this study, C. elegans tissue
expression data was examined. Within the 8474 experiments (see
Methods), the following lists the number of experiments where
expression in that tissue was seen: 2513 – pharynx, 2808 – muscle,
4218 – neurons, 570 nuclei, and 3157 – intestines. Given that less
than 1/3 of the proteins in C. elegans have expression in the
pharynx, this study significantly enriches for the pharynx tissue
with the chi-square goodness of fit test (x2 = 13.41, P , 0.005).
The other tissues were not significantly enriched in our study.
Here we provide a unique prospective for prioritizing drug
targets for infectious diseases by looking at PPI targets, rather than
single proteins. Exploring PPIs as drug targets significantly
expands the number of drug targets and provides many new
avenues for therapies. Drugs that target PPIs are thought to be the
next frontier in therapeutics, and our methodology provides an
innovative means of uncovering desperately-needed, novel drug
targets for the scourge of parasitic worm infections. As PPI
interaction databases and genomic sequences become more
available, this approach will provide innovative drug targets for
many different parasites and pathogens.
Methods
Proteome Databases and Orthologous Groups
The proteomes of various nematodes and hosts were obtained
from a number of different sites in 2009 (Table 1). For species
where alternative splicing has been found to be present (B. malayi,
C. elegans, M. incognita, H. sapiens, A. thaliana), only the longest
isoform was used in the analysis. Orthologous groups were built
using OrthoMCL[37] with default parameters. The orthologous
groups were placed in bins, depending on the trophic ecology of
the species present in the group (Figure 1 and 2A). For example,
there are: bins that include and exclude orthologous groups
containing human proteins, bins for the plant parasites and C.
elegans that include and exclude orthologous groups containing A.
thaliana proteins, and bins with orthologous groups from the plant
parasites and C. elegans that exclude orthologous groups containing
A. thaliana and H. sapiens proteins.
Protein-Protein Interactions
C. elegans protein-protein interactions (PPIs) based on experi-
mental interaction evidence from two databases were used: the C.
elegans Molecular INeraction database (MINT) database[38] (July
2009) with 7,353 PPIs and the IntAct PPI database[39] 10,445
(September 2009). If one of the proteins in the PPI lacked a
UniProt ID, the interaction was omitted. A conversion between C.
elegans gene name and UniProt ID is in Table S12. The C. elegans
proteins within each bin were compared to the PPI databases, and
a PPI was considered a hit if both proteins in the interaction were
found within the same bin. When more than one C. elegans protein
was present in an orthologous group, all C. elegans proteins within
the orthologous group were mapped to a UniProt ID and then it
was determined if a PPI was present. When multiple sequences
from other species were in the same orthologous group, they were
all mapped to the same UniProtID based on C. elegans. Within
each taxonomically restricted bin, the IntAct database had more
PPIs than MINT.
Terms in Scoring Function
RNAi phenotypes for C. elegans (www.wormbase.org WS195;
downloaded on August 2009) were grouped based on Kumar et
al[15]. The complete list of RNAi phenotypes sorted by bin is
available as Table S13. InterProScan[40] (release 4.5) was run on
all the helminth and playhelminth species, and the InterProIDs
were compared to the list of InterProIDs considered druggable by
Hopkins[32]. The result was incorporated into the scoring
function.
To identify similarity to the Protein Data Bank (September
2009), each protein within the different bins was screened using
WU-BLASTP (wordmask= seg topcomboN=1). Only WU-
BLASTP hits with percent identity greater than 25, fraction of
length greater than 0.5 were considered (Figure 1). All sequence
alignments between the orthologous and homologous proteins
were done using MUSCLE[41] to further determine the specificity
between the sequences found via WU-BLASTP. The PDB
homology score was added in only if both proteins had homology
to a protein in the PDB. The PDB homology score was based on
the best scoring sequence from the orthologous group.
To determine if indels were present, the alignment of nematode
sequences and reference sequences was done in a step-wise process
for proteins that had orthologs in the host. First, the C. elegans
sequences from the orthologous groups were extracted, then these
sequences were compared against full-length proteins that were
publically available in the NCBI database (built 5-26-2009). The
WU-BLASTP parameters involved hitdistance= 40 and word-
mask= seg, and the results were parsed with a cutoff of 1e23. The
sequences were taxonomically restricted to those within Vertebrata
and were combined with the H. sapiens sequences from the
orthologous groups. These sequences will be referred to in this
paper as reference sequences for bins where a H. sapiens ortholog
was considered. For Bin 12, the reference sequences were built by
considering sequences taxonomically restricted to Embryophyta.
The reference sequences homologous to each C. elegans protein from
the various orthologous groups were aligned using MUSCLE[41].
The nematode specific sequence profiles from each orthologous
group were aligned to the corresponding reference sequence
profiles using CLUSTALW[42]. Insertions and deletions specific
to nematodes were determined in a method similar to Wang
et al [43] and were based on the CLUSTALW profile alignments.
Briefly, if the gaps were not present in the reference sequences, the
gap was noted as a nematode specific deletion. If there were gaps
shared by all reference sequences and no nematode sequences, the
sequences were referred to as a nematode-specific insertion. If there
were multiple sequences from a single nematode species in an
orthologous group, the indel had to be present in at least one
sequence within a species. Nematode-specific insertions and
deletions were scored within the scoring function.
Scoring
The following scoring function was used to rank the hits with
orthologs in the host:
Score~
X2
i~1
(Diz(Fi ! 100))
2
z(Ri ! 0:75)zIizAi
! "
where D=percent sequence identity between query sequence and
the sequence of PDB structure; F= fraction of length between the
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PDB sequence and query sequence; I = 50 per protein with an
indel; A= 50 per protein considered ‘‘druggable’’ by Hopkins;
R= score from C. elegans RNAi phenotype bins as listed below:
larval/adult lethal/arrest = 100, embryonic lethal = 90, sterility =
80, morphology = 80, growth = 70, movement = 60, vulva = 50,
other = 10. To balance the PDB homology and RNAi score, the
RNAi score was multiplied by 0.75. The scoring broke up the study
into three different catagories: PPI-Nem (interactions specific to
nematodes), PPI-Indel1 (interactions where one protein had a
nematode-specific indel), and PPI-Indel2 (interactions where both
proteins had nematode-specific indels). For PPI-Nem, I and A were
omitted. If a PPI in PPI-Nem had 100% sequence homology, the
entire sequence was present in the PDB, and the RNAi phenotype
was larval/adult lethal/arrest, the maximum score that could be
achieved is 350. In the case of PPIs in PPI-Indel, a PPI with 100%
sequence homolog, the entire sequence present in the PDB, the
RNAi phenotype of larval/adult lethal arrest, both proteins
considered druggable, and both proteins containing indels would
receive a maximum score of 550.
Expression Profile, Gene Onthology Annotation, and
Modelling
Expressed sequence tags (EST) based expression data for C.
elegans, T. spiralis, B. malayi, M. hapla, M. incognita were downloaded
from dbEST division of GenBank (September 2009). The ESTs
were mapped to the proteins from species they originated from
using WU-BLASTX (W=4, T= 20, B= 1,V= 1,topcomboN=1)
and the expression profile recorded. GO associations of the all
helminth and platyhelminth proteins were made by running
InterProScan[40] (release 4.5) (Figure 1). Tissue expression for C.
elegans was taken from WormMart (www.wormbase.org).
Molecular modeling package (MODELLER 9v7[44]) was used
to create homology models of nematode proteins orthologous to
Q03601 and Q20329 and their homologs in H. sapiens and A.
thaliana (Figure 4). The PDB template used for homology modeling
was chosen using the profile build function in MODELLER. A
sequence alignment between the PDB template and individual
orthologs of Q03601 and Q20329 in nematodes and homologs in
H. sapiens and A. thaliana was done using the BioInfo metaser-
ver[45]. MODELLER used the sequence alignment from the
Meta Server and the template PDB structure (1Q7F for Q03601
and 1D4X for Q20329) to generate five different homology
models. The five homology models created by MODELLER were
refined using the ClassicRelax protocol in Rosetta3.0[46]. The five
models were assessed for quality using their full-atom energy from
Rosetta3.0 and two additional programs, Prosa[47] and Molprob-
ity[48], and the best structure was used for subsequent analysis.
MODELLER was also used for initial modeling of O01427 using
1FOT and 2JDO. The alignment was done using both
MODELLER and the BioInfo metaserver. TASSERLite[49]
was ultimately run on O01427 due to incomplete structural
resolution for part of the homologous protein in the PDB.
Fluorescent In situ Hybridization (FISH)
When choosing targets for in situ testing, the expression in the
life stages of C. elegans (EST data) and B. malayi (microarray
expression data (Li, unpublished)) were considered. Ideally, we
wanted to test for proteins via FISH that were expressed in the
adult worm stages because this is the stage that resides in the host.
In addition, the tissue expression in C. elegans (www.wormbase.org)
and A. suum (Mitreva, unpublished) were used to determine if the
proteins in the PPI were expressed in the same tissue. Proteins
containing indels were checked to ensure alternative splicing did
not occur in the indel region of isoforms.
Adult B. malayi worms were fixed for 24–72 h in DEPC-treated
4% buffered formaldehyde and embedded in paraffin using
standard histological procedures. Sections were deparaffinized
and partially digested using pepsin HCl (DakoCytomation,
Hamburg, Germany) for approximately 7 minutes and hybrid-
ized at 37 uC overnight in a dark humid chamber using 200 ng/
ml of custom made biotin (IDT) and digoxygenin (Invitrogen)
labeled oligonucleotide probes (see Table S14). Probes were
checked in silico for specificity using BLAST search. A swap of
oligonucleotide label was used to ensure that the staining pattern
was not affected by the choice of the label. The complementary
sense sequence was used as a negative control probe. The
hybridization buffer contained 50% formamide, 5XSSC, 0.3 mg/
ml yeast tRNA, 100 mg/ml heparin, 1X Denhart’s Solution,
0.1% CHAPS and 5mM EDTA. One stringency wash (Dako-
Cytomation) was performed at 42uC for 30 minutes. The slides
with hybridized with both antisense (or sense) probes were
incubated with 5 mg/ml streptavidin-AlexaFluor 488 conjugate
(Invitrogen) and 1 mg/ml anti-digoxigenin-Rhodamin Fab Frag-
ment (Roche) for 30 minutes at room temperature. Both
conjugates were diluted in PBS with 0.5 % BSA. Finally sections
were rinsed briefly in PBS and covered with a cover slip with
ProLong Gold antifade reagent that contains DAPI (Invitrogen).
This embedding reagent enables simultaneous fluorescence-based
detection of condensed DNA. Sections were examined using a
wide field fluorescence microscope (WFFM, Zeiss Axioskop 2
MOT Plus) with a plan-apochromat 100X oil objective or with a
Zeiss LSM 510 META (Zeiss, Jena, Germany) confocal laser
scanning microcope equipped with a plan-apochromat 63X oil
objective and an argon laser for excitation at 488 nm or an HeNe
laser for excitation at 543 nm. Confocal Z slices of 0.4 mm were
obtained using the Zeiss LSM software.
In situ hybridization (ISH) in M. incognita
Orthologs of Q03601 (Minc18824) and Q20329 (Minc03587
and Minc058765) were retrieved from the genome of M. incognita
(http://www.inra.fr/meloidogyne_incognita/). PCR templates for
probe synthesis were amplified from L2 first strand cDNAs using
gene-specific oligonucleotides (Table S5). DNA sense and anti-
sense probes were synthesized by asymmetric PCR using the same
oligonucleotides and digoxigenin-labeled dCTP. In situ hybridiza-
tions were performed as described by Rosso et al.[50] Briefly,
freshly hatched J2s were fixed in 2% paraformaldehyde for 16 h at
4uC and 4 h at room temperature. Nematodes were cut into
sections and permeabilized with proteinase K, acetone and
methanol. The sections were hybridized at 37uC with the sense
or antisense probe. Nematode sections were incubated in anti-
digoxigenin antibody conjugated to alkaline phoshatase. Bound
probes were detected by alkaline phosphatase activity staining
using NBT (Nitro-Blue Tetrazolium Chloride) /BCIP (5-Bromo-4-
Chloro-3’-Indolyphosphate p-Toluidine Salt) substrates.
Supporting Information
Methods S1 Additional and more detailed methods.
(DOC)
Text S1 Additional discussion on PPI drug targets
found in the study.
(DOC)
Video S1 Full rotation of a 6 mm section of morula stage
embryos labeled for mRNA of Q19126 [XP_00189449.1]
(green) and O01427 [XP_001892118.1] (red).
(MOV)
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Figure S1 Sequence alignment of O01427. The indels are
noted with red boxes.
(DOC)
Figure S2 A. H&E stain of a midbody section of a female
B. malayi showing the anatomy of the examined parasite
sections. I, intestine; uterus, u; m, morula stage embryos. B.
Granular staining (arrows) for Q19126 [XP_00189449.1] mRNA
in the cytoplasm of morula stage embryos in the midbody region of
a female B. malayi. Weeker staining was observed in the
hypodermis (h) and the uterus epithelium (ue). The biotin labeled
probe was detected using AlexaFluor 488-labeled streptavidin
(green). C. Granular staining (arrows) for O01427
[XP_001892118.1] mRNA in the cytoplasm of egg cells and
early morula stage embryos. The biotin labeled probe (label
switch) was detected using AlexaFluor 488-labeled streptavidin
(green). D-F. Confocal laser scanning microscopy (LSM). D
Granular staining (arrows) for Q19126 [XP_00189449.1] mRNA
in the cytoplasm of morulae. The biotin labeled probe was
detected using AlexaFluor 488-labeled streptavidin (green). E.
Identical section as in D showing granular staining (arrows) for
O01427 [XP_001892118.1] mRNA in the same embyos. The
digoxygenin labeled probe was detected using a Rhodamin
conjugated anti-digoxygenin antibody (red). F. Overlay of D
and E showing co-localization of expression of both genes. For 3
dimensional rotation of this section see Video S1. G Another
overlay showing co-localization in morula stage embryos. H.
Serial section to E showing the overlay for both sense probes (no
DAPI) indicating the absence of specific labeling. I. Co-
localization of RNA granules (arrow) positive for P46822
[XP_001895440.1] and Q17581 [XP_001895440.1] in pretzel
stage embryos. J Pretzel stage embryo at higher magnification
showing co-localization (arrows) in a number of granules. K. LSM
image of co-localization in pretzel stage embryos showing the same
pattern (no DAPI). L. Serial section to K, but hybridized with both
sense probes (no DAPI) indicating the absence of specific labeling.
Scale bar 10 mm.
(DOC)
Figure S3 In situ hybridization of Q03601 (Minc18824)
and Q20329 (Minc03587 and Minc058765) orthologs on
Meloidogyne incognita L2. Transcripts were detected using
immunostaining of digoxidenin-labeled antisense probes specific to
Minc18824 (A,B) or specific to both Minc03587 and Minc058765
(C,D). For control, in situ hybridizations were performed with the
sense Minc18824 (E) and sense Minc03587 -Minc058765 (F)
probes. Expression co-localization was evidenced by the presence
of the transcripts in the anterior part of the intestine (arrows) and
the pharynx (arrow heads). Bar = 10 mm.
(DOC)
Figure S4 A. Sequence alignment of Q03601 sequences
from orthomcl, as well as homologous proteins from H.
sapiens. The secondary structure prediction from the meta
server is also shown in the alignment. Blue ‘‘E’s’’ represent beta-
sheets, and red ‘‘C’s’’ represent loop regions. Much of the
sequence diversity is isolated to the loop regions, thereby creating
an accessible method for targeting Q03601 for a nematode specific
drug. The loop regions are boxed in red. B. The boxed structures
with sequence diversity are mapped to a homology model of
Q03601 and highlighted in orange.
(DOC)
Figure S5 T. spiralis, C. elegans, and H. sapiens
homology models of A. Q03601, B. Q20329, and C. M.
hapla and A. thaliana homology models of Q20329
colored by electrostatic potential in vacuum. Q03601
did not have any protein sequences in A. thaliana with homology to
M. hapla and M. incognita. Although regions of these proteins have
homology to H. sapiens (A and B) and A. thaliana (C), the charges on
the surface of H. sapiens and A. thaliana proteins are different from
the charges on the surface of the nematode proteins. Further,
orthomcl did not group the H. sapiens or A. thaliana proteins in the
same orthologous groups as the nematode proteins.
(DOC)
Table S1 Full list of PPI targets in each of the three
major groups: specific to nematodes (PPI-Nem), where
both proteins contain indels with respect to human host
(PPI-Indel2), with one indel with respect to human host
(PPI-Indel1).
(DOC)
Table S2 PPI-Indel1: Plant parasite PPIs with one indel
with respect to Arabidopsis host. The cutoff score was 399.
The following symbols were used to indicate specific features:
* indicates druggable, PPIs with + indicate protein with indel,
a RNAi phenotype 1=Larval/Adult Lethal/Arrest, 2 =Embry-
onic Lethal, 3 = Sterility, 4 =Morphology, 5 =Growth, 6=Move-
ment, 7 =Vulva, 8 =Other; b Indicates analysis group (Nem,
Indel2, and Indel1) and also the database where the PPI was found
(M=MINT and I= IntAct), c Stages are listed as L1, L2, L3, L4,
egg (Eg), embryo (Em), and Adult (A), d Localization in C. elegans
listed as pharynx (P), intestine (I), reproductive (R), muscle (M),
hypodermis (H), nervous system (N), somatic (S), embryo (E).
(DOC)
Table S3 PPI-Indel2: Plant parasite PPIs where both
proteins contain indels with respect to Arabidopsis host.
The cutoff score was 393. The following symbols were used to
indicate specific features: * indicates druggable, PPIs with +
indicate protein with indel, a RNAi phenotype 1=Larval/Adult
Lethal/Arrest, 2 =Embryonic Lethal, 3 = Sterility, 4 =Morpholo-
gy, 5 =Growth, 6=Movement, 7 =Vulva, 8 =Other; b Indicates
analysis group (Nem, Indel2, and Indel1) and also the database
where the PPI was found (M=MINT and I= IntAct), c Stages are
listed as L1, L2, L3, L4, egg (Eg), embryo (Em), and Adult (A),
d Localization in C. elegans listed as pharynx (P), intestine (I),
reproductive (R), muscle (M), hypodermis (H), nervous system (N),
somatic (S), embryo (E).
(DOC)
Table S4 The total score broken down into terms for
the full list of PPI targets in each of the three major groups:
specific to nematodes (PPI-Nem), where both proteins contain
indels with respect to human host (PPI-Indel2), with one indel with
respect to human host (PPI-Indel1). The score is broken down into
the terms in the scoring function, so that the PPI can be evaluated
for further investigation.
(DOC)
Table S5 Oligonucleotide probes used for ISH. Sense
probes with the dogoxigenin label were used as controls for each
probe.
(DOC)
Table S6 Taxonomically restricted orthologous groups.
(DOC)
Table S7 PPIs from MINT and IntAct (PPI-Nem).
(DOC)
Table S8 PPIs from MINT and IntAct (PPI-Indel).
(DOC)
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Table S9 PPI-Nem: Unique protein-protein interactions
in each bin found from the MINT and IntAct Databases.
Interactions in bold were found in both the MINT and IntAct
Databases.
(DOC)
Table S10 PPI-Nem: Unique protein-protein interac-
tions in each bin found from the MINT and IntAct
Databases where both proteins involved in the protein-
protein interaction had an RNAi phenotype. Interactions in
bold were found in both the MINT and IntAct Databases.
(DOC)
Table S11 PPI-Nem: PPIs in which one of the proteins
has an RNAi phenotype. These proteins might be good targets
for subsequent RNAi experiments. Interactions in bold were found
in both the MINT and IntAct Databases.
(DOC)
Table S12 Conversion of UniprotIDs to C. elegans gene
IDs.
(DOC)
Table S13 Complete list of RNAi phenotypes sorted by
bin.
(DOC)
Table S14 Oligonucleotide probes used for FISH. Sense
probes with the respective label were used as controls for each
probe.
(DOC)
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